Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (401-410 of 546) with videos related to

Pageof 55
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 5, 2023
Proliferation and apoptosis after whole-body irradiation: longitudinal PET study in a mouse modelMaria Meindl, Alexandra Bläske, Katja Steiger, et al.
Neuro-Oncology|May 12, 2019
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patientsNorbert Galldiks, Marcus Unterrainer, Natalie Judov, et al.
Neuroimage|October 9, 2017
Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [<sup>18</sup>F]GE180 PET quantificationMaximilian Deussing, Tanja Blume, Lena Vomacka, et al.
Frontiers in Aging Neuroscience|June 23, 2018
Comparison of <sup>18</sup>F-T807 and <sup>18</sup>F-THK5117 PET in a Mouse Model of Tau PathologyMatthias Brendel, Behrooz H Yousefi, Tanja Blume, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
Single-Cell Radiotracer Allocation via Immunomagnetic Sorting to Disentangle PET Signals at Cellular ResolutionLaura M Bartos, Sebastian T Kunte, Philipp Beumers, et al.
Neuroimage|October 3, 2009
Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidarChristian la Fougère, Guido Böning, Hero Bartmann, et al.
Oncotarget|October 6, 2016
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneityRudolf A Werner, Constantin Lapa, Harun Ilhan, et al.
The American Journal of Psychiatry|March 5, 2008
Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuseChristoph Fehr, Igor Yakushev, Nina Hohmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registryDieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after <sup>177</sup>Lu-PSMA-617 Radioligand TherapyFriederike Völter, Lena Mittlmeier, Astrid Gosewisch, et al.
Pageof 55

Showing results (401-410 of 546) with videos related to

Sort By:
Pageof 55
European Journal of Nuclear Medicine and Molecular Imaging|October 5, 2023
Proliferation and apoptosis after whole-body irradiation: longitudinal PET study in a mouse modelMaria Meindl, Alexandra Bläske, Katja Steiger, et al.
Neuro-Oncology|May 12, 2019
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patientsNorbert Galldiks, Marcus Unterrainer, Natalie Judov, et al.
Neuroimage|October 9, 2017
Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [<sup>18</sup>F]GE180 PET quantificationMaximilian Deussing, Tanja Blume, Lena Vomacka, et al.
Frontiers in Aging Neuroscience|June 23, 2018
Comparison of <sup>18</sup>F-T807 and <sup>18</sup>F-THK5117 PET in a Mouse Model of Tau PathologyMatthias Brendel, Behrooz H Yousefi, Tanja Blume, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 19, 2022
Single-Cell Radiotracer Allocation via Immunomagnetic Sorting to Disentangle PET Signals at Cellular ResolutionLaura M Bartos, Sebastian T Kunte, Philipp Beumers, et al.
Neuroimage|October 3, 2009
Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidarChristian la Fougère, Guido Böning, Hero Bartmann, et al.
Oncotarget|October 6, 2016
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneityRudolf A Werner, Constantin Lapa, Harun Ilhan, et al.
The American Journal of Psychiatry|March 5, 2008
Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuseChristoph Fehr, Igor Yakushev, Nina Hohmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registryDieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after <sup>177</sup>Lu-PSMA-617 Radioligand TherapyFriederike Völter, Lena Mittlmeier, Astrid Gosewisch, et al.
Pageof 55